» Articles » PMID: 36985836

Some Nanocarrier's Properties and Chemical Interaction Mechanisms with Flavones

Overview
Journal Molecules
Publisher MDPI
Specialty Biology
Date 2023 Mar 29
PMID 36985836
Authors
Affiliations
Soon will be listed here.
Abstract

Flavones such as 7,8-dihydroxyflavone (tropoflavin), 5,6,7-trihydroxyflavone (baicalein), 3',4',5,6-tetrahydroxyflavone (luteolin), 3,3',4',5,5',7-hexahydroxyflavone (myricetin) 4',5,7-trihydroxyflavone (apigenin), and 5,7-dihydroxyflavone (chrysin) are important both for their presence in natural products and for their pharmacological applications. However, due to their chemical characteristics and their metabolic processes, they have low solubility and low bioavailability. Knowledge about the physicochemical properties of nanocarriers and the possible mechanisms of covalent and non-covalent interaction between nanoparticles (NPs) and drugs is essential for the design of nanocarriers to improve the bioavailability of molecules with pharmacological potential, such as tropoflavin, baicalein, luteolin, myricetin, apigenin, and chrysin. The parameters of characterization of some NPs of these flavones, such as size, polydispersity index (PDI), zeta potential, encapsulation efficiency (EE), and % release/time, utilized in biomedical applications and the covalent and non-covalent interactions existing between the polymeric NPs and the drug were analyzed. Similarly, the presence of functional groups in the functionalized carbon nanotubes (CNTs), as well as the effect of pH on the % adsorption of flavonoids on functionalized multi-walled carbon nanotubes (MWCNT-COOH), were analyzed. Non-covalent interaction mechanisms between polymeric NPs and flavones, and covalent interaction mechanisms that could exist between the NPs and the amino and hydroxyl functional groups, are proposed.

Citing Articles

Combination Therapy and Phytochemical-Loaded Nanosytems for the Treatment of Neglected Tropical Diseases.

Soto-Sanchez J, Garza-Trevino G Pharmaceutics. 2024; 16(10).

PMID: 39458571 PMC: 11510106. DOI: 10.3390/pharmaceutics16101239.


The potential effect of natural antioxidants on endothelial dysfunction associated with arterial hypertension.

Caminiti R, Carresi C, Mollace R, Macri R, Scarano F, Oppedisano F Front Cardiovasc Med. 2024; 11:1345218.

PMID: 38370153 PMC: 10869541. DOI: 10.3389/fcvm.2024.1345218.


Selected Flavonols in Breast and Gynecological Cancer: A Systematic Review.

Wendlocha D, Krzykawski K, Mielczarek-Palacz A, Kubina R Nutrients. 2023; 15(13).

PMID: 37447264 PMC: 10346890. DOI: 10.3390/nu15132938.

References
1.
Hillaireau H, Couvreur P . Nanocarriers' entry into the cell: relevance to drug delivery. Cell Mol Life Sci. 2009; 66(17):2873-96. PMC: 11115599. DOI: 10.1007/s00018-009-0053-z. View

2.
Aiello P, Consalvi S, Poce G, Raguzzini A, Toti E, Palmery M . Dietary flavonoids: Nano delivery and nanoparticles for cancer therapy. Semin Cancer Biol. 2019; 69:150-165. DOI: 10.1016/j.semcancer.2019.08.029. View

3.
Qiu J, Gao X, Wang B, Wei X, Gou M, Men K . Preparation and characterization of monomethoxy poly(ethylene glycol)-poly(ε-caprolactone) micelles for the solubilization and in vivo delivery of luteolin. Int J Nanomedicine. 2013; 8:3061-9. PMC: 3748903. DOI: 10.2147/IJN.S45062. View

4.
Elsabahy M, Wooley K . Cytokines as biomarkers of nanoparticle immunotoxicity. Chem Soc Rev. 2013; 42(12):5552-76. PMC: 3665642. DOI: 10.1039/c3cs60064e. View

5.
Morais R, Novais G, Sangenito L, Santos A, Priefer R, Morsink M . Naringenin-Functionalized Multi-Walled Carbon Nanotubes: A Potential Approach for Site-Specific Remote-Controlled Anticancer Delivery for the Treatment of Lung Cancer Cells. Int J Mol Sci. 2020; 21(12). PMC: 7348916. DOI: 10.3390/ijms21124557. View